Ross Ian Baker

10PUBLICATIONS
90CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRespiratory diseasesHaematologyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Apr 25, 2025
Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Ferdows Atiq, Robin Blok, Calvin B van Kwawegen

|Mar 18, 2025
Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.

Ciara Byrne, Soracha Ward, Jamie O'Sullivan

|Mar 17, 2025
Management of Bleeding, Thrombotic and Pregnancy-Related Complications in Women with Myeloproliferative Neoplasms: A Case-Based Review Focusing on Sex-Specific Challenges.

Thita Chiasakul, Ross I Baker

|Jul 12, 2024
The aptamer BT200 blocks interaction of K1405-K1408 in the VWF-A1 domain with macrophage LRP1.

Alain Chion, Ciara Byrne, Ferdows Atiq

Pageof 2

Frequent Collaborators

6 joint publications

James S O'Donnell

4 joint publications

Roger J S Preston

4 joint publications

Mary Byrne

3 joint publications

Ciara Byrne